5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 16.15▲ | 16.21▼ | 16.23▼ | 16.05▲ | 15.13▲ |
MA10 | 16.14▲ | 16.23▼ | 16.74▼ | 15.53▲ | 15.31▲ |
MA20 | 16.21▼ | 16.82▼ | 16.79▼ | 15.24▲ | 16.13▲ |
MA50 | 16.23▼ | 16.35▼ | 15.67▲ | 15.55▲ | 17.34▼ |
MA100 | 16.79▼ | 15.63▲ | 15.29▲ | 16.17▼ | 13.61▲ |
MA200 | 16.47▼ | 15.25▲ | 15.42▲ | 17.33▼ | 9.77▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.010▲ | -0.117▼ | -0.180▼ | 0.230▲ | -0.075▼ |
RSI | 46.174▼ | 42.227▼ | 47.356▼ | 55.610▲ | 49.398▼ |
STOCH | 61.925 | 18.940▼ | 10.060▼ | 64.313 | 25.085 |
WILL %R | -49.153 | -91.176▼ | -91.803▼ | -46.361 | -50.498 |
CCI | 104.762▲ | -57.285 | -89.224 | 143.395▲ | 20.650 |
CDL | $PLSE Engulfing Candlestick Pattern Detected | Set Alert |
Wednesday, August 13, 2025 12:37 AM
Despite rising costs, Pulse Biosciences Inc (PLSE) makes significant strides in regulatory progress and clinical innovations.
|
Tuesday, August 12, 2025 06:07 PM
Pulse Biosciences (PLSE) reports Q2 2025 momentum in nsPFA clinical adoption, commercialization, and IDE progress. Revenue forecasted for H2 2025.
|
Friday, August 01, 2025 10:04 AM
Detailed price information for Pulse Biosciences CS (PLSE-Q) from The Globe and Mail including charting and trades.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/08/25 | 17.43 | 17.61 | 15.97 | 16.16 | 309,150 |
14/08/25 | 16.65 | 17.88 | 16.22 | 17.31 | 330,374 |
13/08/25 | 15.30 | 17.06 | 15.19 | 16.79 | 362,408 |
12/08/25 | 14.90 | 15.235 | 14.755 | 15.10 | 180,821 |
11/08/25 | 14.55 | 14.9821 | 14.49 | 14.88 | 126,649 |
08/08/25 | 14.83 | 14.90 | 14.455 | 14.71 | 101,101 |
07/08/25 | 15.38 | 15.42 | 14.46 | 14.72 | 169,924 |
06/08/25 | 15.23 | 15.515 | 15.01 | 15.34 | 159,828 |
05/08/25 | 15.09 | 15.385 | 14.775 | 15.25 | 108,650 |
04/08/25 | 14.79 | 15.07 | 14.59 | 15.07 | 131,345 |
|
|
||||
|
|
||||
|
|